ARCHIVES

Panel Says Tamoxifen Remains Standard for Preventing Breast Cancer

This article is from The Cancer Letter archive.

Vol. 28 No. 21 | May 24, 2002

Download PDF Visit The Full Archive

Related Articles

ODAC Recommends Approval Of Paxen; Will IVAX Break Into $1 Billion Market

September 26, 1997

House Panel Targets AWP For Medicare Drug Pricing.

October 5, 2001

Center Studies Prevention For Endometrial Cancer

February 25, 2005

Nurse Oncology Society Growing, developing Care Guidelines

August 19, 1977

Komen Foundation Awards New Grants

October 20, 1995

Breast Cancer Task Force Must Take More Active Role In RFP Development, New Chairman Insists

November 14, 1975